These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7194302)

  • 1. [CEA--a parameter in the course of chemotherapy of ovarian cancer].
    Urdl W; Pickel H; Pürstner P; Schrödl P
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():90-7. PubMed ID: 7194302
    [No Abstract]   [Full Text] [Related]  

  • 2. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
    Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of ovarian cancer].
    Pickel H; Lahousen M
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():77-83. PubMed ID: 6260600
    [No Abstract]   [Full Text] [Related]  

  • 4. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer.
    Rose PG
    Oncologist; 2005 Mar; 10(3):205-14. PubMed ID: 15793224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.
    Decker DG; Malkasian GD; Mussey E; Johnson CE
    Am J Obstet Gynecol; 1967 Mar; 97(5):656-65. PubMed ID: 4959953
    [No Abstract]   [Full Text] [Related]  

  • 6. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
    Irvine T; Scott M; Clark CI
    Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen (CEA): its role as a tumour marker in breast cancer.
    Doyle PJ; Nicholson RI; Groome GV; Blamey RW
    Clin Oncol; 1981 Mar; 7(1):53-8. PubMed ID: 7214765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carcinoembryonic antigen in gastrointestinal cancer].
    Halevy A; Adam Y; Eshchar J; Zaidman J; Sherf S
    Harefuah; 1980 Aug; 99(3-4):57-9. PubMed ID: 7203205
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer.
    Pérez-López ME; Curiel T; Gómez JG; Jorge M
    Anticancer Drugs; 2007 Jun; 18(5):611-7. PubMed ID: 17414631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical relevance of tumor markers for follow-up and therapy planning in ovarian cancer].
    Böhm W; Lücke R; Ertle B; Benz R; Deinert S
    Arch Gynecol Obstet; 1989; 245(1-4):640-2. PubMed ID: 2802749
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of carcinoembryonic antigen in the monitoring of colorectal cancer].
    Lagache G
    Verh K Acad Geneeskd Belg; 1980; 42(1):60-73. PubMed ID: 7445709
    [No Abstract]   [Full Text] [Related]  

  • 13. [CEA monitoring of gynecologic tumor patients using a simplified CEA-radioimmunoassay].
    Hörst M; Wiest W
    Fortschr Med; 1982 Mar; 100(11):482-3. PubMed ID: 7076078
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer.
    Fleming GF; Waggoner SE; Rotmensch J; Skoog LA; Langhauser C
    Gynecol Oncol; 1997 Apr; 65(1):42-5. PubMed ID: 9103389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is the clinical significance of CEA determination in patients with colorectal carcinoma exaggerated?].
    Wedell J; Meier zu Eissen P; Meier zu Eissen J; Blanco A; van Calker H; Koldowski P; Schlipköter HW
    Med Welt; 1981 Mar; 32(11):343-7. PubMed ID: 7219141
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy-induced changes of CA 125 in patients with epithelial ovarian cancer.
    Søgaard CH; Lindegaard JC; Havsteen H; Nielsen OS; Mogensen O
    Gynecol Oncol; 2005 May; 97(2):410-2. PubMed ID: 15863138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.
    Nakayama T; Watanabe M; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of CEA and serum glycoprotein findings in tumor diagnosis].
    Wintzer G; Koch O; Uhlenbruck G
    Internist (Berl); 1980 Apr; 21(4):181-8. PubMed ID: 6998906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.